ArticleCureus2025
Progressive Multifocal Leukoencephalopathy as the Initial Presentation of Undiagnosed HIV Infection: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal complication associated with advanced HIV infection, caused by the reactivation of the John Cunningham (JC) virus in immunocompromised individuals. Diagnosis is challenging due to nonspecific symptoms and the need for specialized diagnostic tools, which may not be readily available in resource-limited settings. Early initiation of antiretroviral therapy (ART) is critical for managing the condition, though prognosis remains poor in advanced cases. We present the case of a 30-year-old male with newly diagnosed HIV who presented with a two-week history of fever, headache, hiccups, and unconsciousness. Initially suspected to have encephalitis, the patient was empirically treated with ceftriaxone, acyclovir, and later vancomycin. HIV testing, performed with an independent kit, confirmed a positive diagnosis, and ART was started. A CSF analysis revealed findings suggestive of tuberculous meningitis, and treatment for tuberculosis was initiated. However, subsequent re-evaluation of MRI images raised suspicion of PML, which was confirmed radiologically. Due to resource constraints, JC virus polymerase chain reaction testing was not conducted, and further diagnostic tests were unavailable. The patient's condition continued to deteriorate despite supportive care, and he succumbed to complications of immunosuppression on the 13th day of admission. This case highlights the diagnostic challenges of PML in patients with HIV, especially in settings with limited resources. The patient's initial presentation with nonspecific neurological symptoms and delayed diagnosis of HIV and PML contributed to poor outcomes. Early ART initiation remains essential, though its efficacy may be limited in cases of severe immunosuppression. PML should be considered in the differential diagnosis of neurological symptoms in patients with newly diagnosed or advanced HIV. Early ART initiation is crucial, though the prognosis remains poor in severe cases. This case emphasizes the importance of comprehensive neurological assessment and vigilance in individuals with HIV presenting with new-onset neurological symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.